RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE AND COMBINED WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA. (June 2017) - Westin, J.R.; Fayad, L.; Oki, Y.; Nastoupil, L.; Hagemeister, F.; Turturro, F.; Lee, H.J.; Rodriguez, A.; Young, K.H.; McDonnell, T.; Ford, R.; Neelapu, S.; et al.